Jiers, W.; Sommerfeld-Klatta, K.; Gumustas, M.; Mozdziak, P.; Łukasik-Głębocka, M.; Teżyk, A.; Żaba, Z.; Żaba, C.; Piotrowska-Kempisty, H.
Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals 2025, 18, 1213.
https://doi.org/10.3390/ph18081213
AMA Style
Jiers W, Sommerfeld-Klatta K, Gumustas M, Mozdziak P, Łukasik-Głębocka M, Teżyk A, Żaba Z, Żaba C, Piotrowska-Kempisty H.
Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals. 2025; 18(8):1213.
https://doi.org/10.3390/ph18081213
Chicago/Turabian Style
Jiers, Wiktoria, Karina Sommerfeld-Klatta, Mehmet Gumustas, Paul Mozdziak, Magdalena Łukasik-Głębocka, Artur Teżyk, Zbigniew Żaba, Czesław Żaba, and Hanna Piotrowska-Kempisty.
2025. "Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs" Pharmaceuticals 18, no. 8: 1213.
https://doi.org/10.3390/ph18081213
APA Style
Jiers, W., Sommerfeld-Klatta, K., Gumustas, M., Mozdziak, P., Łukasik-Głębocka, M., Teżyk, A., Żaba, Z., Żaba, C., & Piotrowska-Kempisty, H.
(2025). Analytical Biomarkers for Inflammation Status Monitoring of Psychotropic and Antiepileptic Drugs. Pharmaceuticals, 18(8), 1213.
https://doi.org/10.3390/ph18081213